CBD expansion: Aussie pharma firm outlines Asia nutraceutical plans after China launch

By Cheryl Tay

11-Jun-2019 - Last updated on 11-Jun-2019 at 04:16 GMT

Australian bio-pharmaceutical firm MGC Pharmaceuticals is eyeing expansion in East and South East Asia with its cannabis-based nutraceutical products, after having recently launched in China.

Read the full story here.

Top 10 stories (May 2019

CBD expansion: Aussie pharma firm outlines Asia nutraceutical plans after China launch

Driving India's nutraceutical growth: New trade body launches website and names advocacy boards

Bill Gates-backed probiotic firm Evolve BioSystems makes APAC debut with Singapore, Hong Kong launch

Personalised gummies for skin health: Chinese skincare brand expands into nutrition with beauty-from-within range

From buns to bacteria: 'First-of-its-kind' probiotic facility opens in Australia following Chinese investment

Success from specialisation: Nestlé China attributes growth to organic, A2 and special care infant nutrition NPD

Imports still impress: Survey reveals Chinese consumers place premium on overseas supplements

Aussie exporter eyes China and wider APAC region with new in-house functional food and supplements

Regulatory Review: Dairy ban and diet pills in India, health claims in Singapore, and Nestlé's infant formula controversy

Nature's Care unfazed by China's new CBEC laws, with strong growth spurring confidence after $563m takeover

Related news

Show more

Related products

show more

From Strains to Science: Formulas that Matter

Content provided by SYNBIO TECH INC. | 30-Oct-2024 | White Paper

SynForU is a comprehensive probiotics formula series designed to support diverse health needs.

8X Boost in Vitamin C with LipoAvail™

Content provided by Effepharm Ltd | 10-Oct-2024 | Product Brochure

Vitamin C, a powerful antioxidant, is vital for maintaining normal bodily functions but is unstable and prone to oxidation. As intake increases, the absorption...

White Paper: A new horizon in osteoarthritis treatment: Arthelio® and its clinical benefits

Content provided by ABbiotek Health | 08-Oct-2024 | White Paper

Discover a comprehensive white paper on osteoarthritis (OA), exploring its causes, symptoms, and global impact, alongside an in-depth review of current...

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 27-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

Related suppliers

Follow us

Products

View more

Webinars

Upcoming editorial webinars

05 Nov 2024 Tue Webinar Microbiome Innovations APAC

On-demand webinars

Nutra Champions Podcast

Headlines

Promotional features